Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Angiotech, Johnson & Johnson Unit Settle Litigation - Medical Product Outsourcing

What are you searching for?

Sign in

Angiotech, Johnson & Johnson Unit Settle Litigation

By: Jennifer Whitney

Editor

Angiotech Pharmaceuticals Inc. (ANPI) has settled all outstanding patent litigation with Johnson & Johnson’s (JNJ) Conor Medsystems subsidiary related to Conor’s CoStar paclitaxel stent. As reported, Conor attempted to revoke an Angiotech patent having to do with ” the compositions comprising a polymer and a paclitaxel,” as well as “paclitaxel- eluting stents.” Angiotech said that, at the time of the settlement, there was ongoing litigation in three jurisdictions: the United Kingdom, the Netherlands and Australia. Specific settlement details weren’t disclosed. Angiotech is a Vancouver pharmaceutical and medical-device company. SOURCE: Dow Jones

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters